Results 51 to 60 of about 1,762 (163)

Pinnae and facial hypertrichosis induced by cetuximab

open access: yes, 2023
Introduction: Anti-EGFR targeted anti-cancer treatment is associated with various skin adverse events. Cetuximab is often associated with acneiform papules and skin disorders.
Alevizopoulos, N.   +4 more
core   +1 more source

Barber Say Syndrome (A new case report)

open access: yesIndian Dermatology Online Journal, 2019
Barber Say syndrome (BSS) is a rare ectodermal dysplasia with neonatal onset characterized by congenital generalized hypertrichosis, atrophic skin, ectropion and macrostomia. A literature review showed less than 20 previously reported cases of Barber Say
Mehrdad Rezaei   +2 more
doaj   +1 more source

Bullous aplasia cutis congenita: A report of two cases and brief review of the selected literature [PDF]

open access: yesVojnosanitetski Pregled, 2019
Introduction. Aplasia cutis congenita (ACC) is a rare condition characterized by the focal absence of skin, and sometimes other underlying structures at birth. It may occur as an isolated defect or associated with other anomalies and defects. Bullous ACC
Prćić Sonja   +5 more
doaj   +1 more source

Novel Postzygotic Variants Associated With Hypomelanosis of Ito Expand the ACTB‐Related Neurocutaneous Disease Spectrum

open access: yesClinical Genetics, Volume 110, Issue 3, Page 369-373, September 2026.
We describe a previously unreported phenotype related to postzygotic ACTB variants with hypomelanosis of Ito, characterized by hypopigmentation associated or not with neurodevelopmental features, distinct from Becker presentations, bridging constitutional neurodevelopmental and somatic cutaneous phenotypes.
Estella Castillon   +9 more
wiley   +1 more source

Local Pharmacokinetics and Tolerability of Topically‐Applied Bimatoprost to the Scalp of Male Patients With Androgenetic Alopecia

open access: yesClinical and Translational Science, Volume 19, Issue 9, September 2026.
ABSTRACT Androgenetic alopecia (AGA) is one of the most common causes of hair loss in the male population, characterized by progressive baldness. This study was designed to evaluate the tolerability and local skin pharmacokinetics of bimatoprost in two different formulations in male subjects with AGA.
Sana Khajeh pour   +5 more
wiley   +1 more source

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

open access: yesEquine Veterinary Education, Volume 38, Issue 9, Page e622-e630, September 2026.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken   +5 more
wiley   +1 more source

Cetuximab-induced Facial Hypertrichosis in a Woman Treated for Metastatic Colon Adenocarcinoma

open access: yesOman Medical Journal
The use of anti-epidermal growth factor receptor antibodies, such as cetuximab, is a standard part of the management of metastatic colorectal and head and neck cancers, as they inhibit tumor proliferation.
Rami Abu Omar   +2 more
doaj   +1 more source

Laser Hair Removal With Alexandrite Laser: Tailoring Brushing and Stamping Protocols for Optimal Comfort and Efficiency

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Objectives The study aimed to evaluate the safety and efficacy of the Avalanche brushing protocol across various body regions, assess the clinical outcomes of the combined brushing‐stamping treatment scheme, and compare patient‐reported comfort levels between the two approaches.
Anže Zorman
wiley   +1 more source

Causes and management of hypertrichosis.

open access: yes, 2002
Hypertrichosis is the term used for the growth of hair on any part of the body in excess of the amount usually present in persons of the same age, race, and sex, excluding androgen-induced hair growth.
Trüeb RM
core   +1 more source

Combined 5‐aminolevulinic acid and ferric ammonium citrate treatment promotes hair follicle growth by activating dermal papilla cells

open access: yesFEBS Open Bio, Volume 16, Issue 8, Page 1527-1536, August 2026.
5‐Aminolevulinic acid combined with ferric ammonium citrate (5‐ALA/FAC) stimulates dermal papilla cell activity and promotes hair follicle growth. The treatment enhances ERK and AKT signaling, increases hair‐inductive gene expression, and restores dermal papilla function suppressed by dihydrotestosterone and oxidative stress, resulting in enhanced hair
Han‐Wook Ryu, Eok‐Soo Oh, Sewoon Kim
wiley   +1 more source

Home - About - Disclaimer - Privacy